Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $309.98 USD
Change Today -2.02 / -0.65%
Volume 265.1K
As of 10:37 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - allergan plc (AGN)

Name (Connections)Board RelationshipsTitleKey Developments
Fred Weiss 67 RelationshipsIndependent Director, Chairman of Audit & Compliance Committee and Member of Nominating & Corporate Governance Committee 
Catherine Klema 62 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit & Compliance Committee 
James Bloem 44 RelationshipsDirector, Member of Audit & Compliance Committee and Member of Nominating & Corporate Governance Committee 
Patrick O'Sullivan 29 RelationshipsDirector, Member of Audit & Compliance Committee and Member of Operations & Innovation Committee 

Compensation Committee* - allergan plc (AGN)

Name (Connections)Board RelationshipsTitle
Christopher Bodine 26 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Christopher Coughlin 55 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Ronald Taylor 52 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
AGN Compensation vs. Industry
500.0K
440.8K
Chief Executive Officer
31.4K
280.6K
Chief Financial Officer
Share price activity for ALLERGAN PLC (AGN)
52 Week Price Performance
AGN
Industry Average

Nominating Committee* - allergan plc (AGN)

Name (Connections)Board RelationshipsTitleKey Developments
Ronald Taylor 52 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeActavis plc Announces Resignation of David Buchen as Executive Vice President, North American Generics and International
05/4/15
Fred Weiss 67 RelationshipsIndependent Director, Chairman of Audit & Compliance Committee and Member of Nominating & Corporate Governance CommitteeActavis plc Announces Executive Changes
04/20/15
Christopher Bodine 26 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeActavis plc Announces Board Appointments
03/17/15
Catherine Klema 62 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit & Compliance CommitteeActavis plc Announces Executive Changes
02/10/15
James Bloem 44 RelationshipsDirector, Member of Audit & Compliance Committee and Member of Nominating & Corporate Governance CommitteeActavis plc Announces Senior Management Changes
01/8/15
Christopher Coughlin 55 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Corporate Governance Committee* - allergan plc (AGN)

Name (Connections)Board RelationshipsTitle
James Bloem 44 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Christopher Bodine 26 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Christopher Coughlin 55 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Catherine Klema 62 Relationships--
Ronald Taylor 52 Relationships--
Fred Weiss 67 Relationships--
AGN and Competitor
Insiders vs. External
Board
17%
83%
Allergan plc
7%
93%
Amgen Inc.
9%
91%
Bristol-Myers Squibb Company
8%
92%
Medtronic plc
13%
87%
Eli Lilly and Company
12%
88%
Novo Nordisk A/S
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $309.99 USD -2.01

AGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amgen Inc $156.37 USD +0.65
Bristol-Myers Squibb Co $60.66 USD -0.16
Eli Lilly & Co $83.30 USD -0.44
Medtronic PLC $73.18 USD -0.34
Novo Nordisk A/S kr369.00 DKK -1.10
View Industry Companies
 

Industry Analysis

AGN

Industry Average

Valuation AGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.8x
Price/Book 1.8x
Price/Cash Flow 66.2x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.